Transcatheter arterial chemoembolization in hepatocellular carcinoma

被引：4

作者：

Farinati, F ^{[1
]}

Rinaldi, M

Gianni, S

Marin, G

机构：

[1] Univ Padua, Dept Gastroenterol, I-35100 Padua, Italy

[2] Dolo Gen Hosp, Dept Med, Venice, Italy

来源：

HEPATOLOGY | 1998年 / 28卷 / 05期

关键词：

D O I：

10.1002/hep.510280542

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1441 / 1442

页数：2

共 11 条

[1] Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma:: Results of a randomized, controlled trial in a single institution [J].

Bruix, J ;

Llovet, JM ;

Castells, A ;

Montañá, X ;

Brú, C ;

Ayuso, MD ;

Vilana, R ;

Rodés, J .

HEPATOLOGY, 1998, 27 (06) :1578-1583

[2] Unresectable hepatocellular carcinoma in cirrhosis - Survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization [J].

Farinati, F ;

DeMaria, N ;

Marafin, C ;

Herszenyi, L ;

DelPrato, S ;

Rinaldi, M ;

Perini, L ;

Cardin, R ;

Naccarato, R .

DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (12) :2332-2339

[3]

IKEDA K, 1991, CANCER, V68, P2150, DOI 10.1002/1097-0142(19911115)68:10<2150::AID-CNCR2820681011>3.0.CO

[4]

2-F

[5] PROSPECTIVE AND RANDOMIZED CLINICAL-TRIAL FOR THE TREATMENT OF HEPATOCELLULAR-CARCINOMA - A COMPARISON OF LIPIODOL-TRANSCATHETER ARTERIAL EMBOLIZATION WITH AND WITHOUT ADRIAMYCIN (1ST COOPERATIVE STUDY) [J].

KAWAI, S ;

OKAMURA, J ;

OGAWA, M ;

OHASHI, Y ;

TANI, M ;

INOUE, J ;

KAWARADA, Y ;

KUSANO, M ;

KUBO, Y ;

KURODA, C ;

SAKATA, Y ;

SHIMAMURA, Y ;

JINNO, K ;

TAKAHASHI, A ;

TAKAYASU, K ;

TAMURA, K ;

NAGASUE, N ;

NAKANISHI, Y ;

MAKINO, M ;

MASUZAWA, M ;

MIKURIYA, S ;

MONDEN, M ;

YUMOTO, Y ;

MORI, T ;

ODA, T .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 31 :S1-S6

[6] TREATMENT, RESECTION AND ETHANOL INJECTION IN HEPATOCELLULAR-CARCINOMA - A RETROSPECTIVE ANALYSIS OF SURVIVAL IN 391 PATIENTS WITH CIRRHOSIS [J].

LIVRAGHI, T ;

BOLONDI, L ;

BUSCARINI, L ;

COTTONE, M ;

MAZZIOTTI, A ;

MORABITO, A ;

TORZILLI, G ;

BARBARA, L ;

BOUZARI, H ;

CAPUSSOTTI, L ;

CALVI, A ;

CATURELLI, E ;

COLOMBO, M ;

TOMMASINI, M ;

DOCI, R ;

GENNARI, L ;

FASSATI, L ;

FORNARI, F ;

FRIGERIO, F ;

GARBAGNATI, F ;

GOZZETTI, G ;

LAZZARONI, S ;

MARCHIORI, M ;

NICOLI, N ;

MARIN, G ;

MONTORSI, M ;

PEZZUOLI, G ;

PARISI, P ;

RAPACCINI, GL ;

RICCI, S ;

ROVERSI, RA ;

ROMANI, F ;

ROSSI, P ;

SALMI, A ;

TADDEI, G ;

VETTORI, C .

JOURNAL OF HEPATOLOGY, 1995, 22 (05) :522-526

[7] RANDOMIZED TRIAL OF TARGETED CHEMOTHERAPY WITH LIPIODOL AND 5-EPIDOXORUBICIN COMPARED WITH SYMPTOMATIC TREATMENT FOR HEPATOMA [J].

MADDEN, MV ;

KRIGE, JEJ ;

BAILEY, S ;

BENINGFIELD, SJ ;

GEDDES, C ;

WERNER, ID ;

TERBLANCHE, J .

GUT, 1993, 34 (11) :1598-1600

[8]

OBERTI F, 1995, NEW ENGL J MED, V332, P1256

[9] Transcatheter arterial embolization for advanced hepatocellular carcinoma: The controversy continues [J].

Okada, S .

HEPATOLOGY, 1998, 27 (06) :1743-1744

[10] A RANDOMIZED TRIAL OF HEPATIC ARTERIAL CHEMOEMBOLIZATION IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR-CARCINOMA [J].

PELLETIER, G ;

ROCHE, A ;

INK, O ;

ANCIAUX, ML ;

DERHY, S ;

ROUGIER, P ;

LENOIR, C ;

ATTALI, P ;

ETIENNE, JP .

JOURNAL OF HEPATOLOGY, 1990, 11 (02) :181-184

← 1 2 →